好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

A multicenter, open-label trial of ganaxolone in children with PCDH19 epilepsy
Epilepsy/Clinical Neurophysiology (EEG)
P5 - (-)
236
Authors/Disclosures
Jaakko Lappalainen, MD, PhD (Marinus)
PRESENTER
No disclosure on file
Michael Chez, MD, FAAN (Sutter Medical Group) Dr. Chez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ucb. Dr. Chez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for marinus. Dr. Chez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Catalyst. Dr. Chez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelsi. Dr. Chez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Pharma. Dr. Chez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ucb. Dr. Chez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Catalyst.
No disclosure on file
No disclosure on file
Nicola Specchio Nicola Specchio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Nicola Specchio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for stoke.
Albena I. Patroneva, MD (Harmony Biosciencesw) Dr. Patroneva has nothing to disclose.